GE to Invest in Israeli Company That Developed Swallowable Endoscopic Capsules

Share on Facebook
General Electric Healthcare plans to invest in Check-Cap, an Israeli company developing swallowable endoscopic capsules for imaging inside the GI tract, through its $250 million healthymagination fund, according to a news release.

The capsule differs from competitor Given Imaging's PillCam because it uses low-energy X-rays instead of light. This produces a different image and could eliminate the need for typical GI tract preparation because X-rays penetrate through soft material like food. The technology could be used to screen for colorectal cancer as well as other diseases of the GI tract.

Check-Cap plans to introduce the technology in Europe before the end of 2013 and is currently in talks with the FDA.

Related Articles on Gastroenterology:
Colorectal Cancer Screening Rates by the Numbers: 12 Recent Statistics
Study: Demand for Screening Colonoscopy Down During Recession
Global Endoscopy Market Expected to Grow 13.2% in Next Three Years

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Tennessee endoscopy centers partner with MDSave for colonoscopy bundled pricing: 5 key points

Read Now